From today's PE Week Wire:
Q1 venture capital data is out this morning, and it includes three significant developments. First, venture capital investing reached its highest level in six years, with over $7.05 billion disbursed. Second, biotech (including pharma) was the top sector for the second time in the past three quarters (even though IT still tops healthcare by a 52-37% split). Finally, Southern California-based companies raised more VC funding in Q1 than did New England-based companies, although the latter still had more companies funded.
All of this comes courtesy of the MoneyTree number-crunchers at PricewaterhouseCoopers, National Venture Capital Association and Thomson Financial. Click here for an abundance of downloadable data.